2
12
3
4

 

>
CASE STUDY 1
Parenteral dosage form development of a highly insoluble molecule
>
CASE STUDY 2
Salt form optimization and lyophilized parenteral formulation development
>
CASE STUDY 3
Oral liquid formulation development
>
CASE STUDY 4
Accelerated stability studies to support a screening IND
>
CASE STUDY 5
Lead Optimization: Solubility and formulation screen for efficacy and PK studies

 

Janet Wolfe named an Entrepreneur to Watch by the MIT Enterprise Forum

“Every project is customized to meet our clients’ needs. We do not try to fit their project into a specific technology, but rather find out what they need and then determine the best way to meet their needs…”
Click here to read a complete interview with Janet Wolfe
.

 

© 2004 Wolfe Laboratories, Inc. All rights reserved.